Your browser doesn't support javascript.
loading
Clinical prognostic factors in advanced epithelioid haemangioendothelioma: a retrospective case series analysis within the Italian Rare Cancers Network.
Frezza, A M; Napolitano, A; Miceli, R; Badalamenti, G; Brunello, A; Buonomenna, C; Casali, P G; Caraceni, A; Grignani, G; Gronchi, A; Infante, G; Morosi, C; Saita, L; Simeone, N; Zaffaroni, N; Vincenzi, B; Stacchiotti, S.
Afiliação
  • Frezza AM; Medical Oncology, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: annamaria.frezza@istitutotumori.mi.it.
  • Napolitano A; Medical Oncology, Università Campus Bio-Medico di Roma, Rome, Italy.
  • Miceli R; Department of Clinical Epidemiology and Trial Organisation, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy.
  • Badalamenti G; Medical Oncology, Policlinico Paolo Giaccone, Palermo, Italy.
  • Brunello A; Department of Oncology, Medical Oncology Unit 1, Veneto Institute of Oncology, IRCCS, Padua, Italy.
  • Buonomenna C; Department of Radiology, IRCCS Foundation National Cancer Institute, Milan, Italy.
  • Casali PG; Medical Oncology, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Caraceni A; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy.
  • Grignani G; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
  • Gronchi A; Department of Surgery, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy.
  • Infante G; Department of Clinical Epidemiology and Trial Organisation, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy.
  • Morosi C; Department of Radiology, IRCCS Foundation National Cancer Institute, Milan, Italy.
  • Saita L; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy.
  • Simeone N; Medical Oncology, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy.
  • Zaffaroni N; Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS - Istituto Nazionale Tumori, Milan, Italy.
  • Vincenzi B; Medical Oncology, Università Campus Bio-Medico di Roma, Rome, Italy.
  • Stacchiotti S; Medical Oncology, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy.
ESMO Open ; 6(2): 100083, 2021 04.
Article em En | MEDLINE | ID: mdl-33714008
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hemangioendotelioma Epitelioide Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans País/Região como assunto: Europa Idioma: En Revista: ESMO Open Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hemangioendotelioma Epitelioide Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans País/Região como assunto: Europa Idioma: En Revista: ESMO Open Ano de publicação: 2021 Tipo de documento: Article